Browse by author
Lookup NU author(s): Professor Alan Boddy
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
A method has been devised for the determination of the anticancer drug ifosfamide and its principal metabolites in urine, plasma and cerebrospinal fluid (CSF). The urine and CSF samples are adsorbed onto Amberlite XAD-2 eluting the compounds of interest with methanol. Plasma is deproteinated using cold acetonitrile and centrifuged to yield a clear supernatant. The eluate and supernatant are analyzed by thin-layer chromatography, with spot visualization using 4-(4-nitrobenzyl)pyridine. The plates are photographed for subsequent densitometric analysis. The intra-assay coefficient of variation for each compound in both urine and plasma was less than 10% and the lower limit of detection was 1-mu-g/ml. The method provides a means of determining the full spectrum of metabolic products of ifosfamide in patients and will allow detailed investigations of variability in metabolism and pharmacokinetics of this drug.
Author(s): Boddy, A. V., Idle, J. R.
Publication type: Article
Publication status: Published
Journal: Journal of Chromatography: Biomedical Applications
Year: 1992
Volume: 575
Issue: 1
Pages: 137-142
Print publication date: 13/03/1992
ISSN (print): 0378-4347
ISSN (electronic): 1873-376X
URL: http://dx.doi.org/10.1016/0378-4347(92)80514-Q
DOI: 10.1016/0378-4347(92)80514-Q
Altmetrics provided by Altmetric